Announcements Trials
Browse Landscape

Status

Completed 8Unknown 5Recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1Approved for marketing 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 82Brain Neoplasms 79Glioma 63Neoplasms 16Neuroblastoma 15Meningioma 14Medulloblastoma 13Neurofibromatosis 1 10Ependymoma 10Meningeal Carcinomatosis 9Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 8Neurologic Manifestations 6Diffuse Intrinsic Pontine Glioma 6Astrocytoma 6Spinal Cord Neoplasms 5Recurrence 5Central Nervous System Neoplasms 5Pheochromocytoma 4Paraganglioma 4Oligodendroglioma 4Lung Neoplasms 4Sarcoma 3Rhabdoid Tumor 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neuroma, Acoustic 3Neurofibroma, Plexiform 3Head and Neck Neoplasms 3Ganglioneuroblastoma 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neuroectodermal Tumors × CNS × Clear all
NCT05406947 2023-02-08

Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children

Beijing Tiantan Hospital

Not yet recruiting
350 enrolled
CNS

Glioma, Medulloblastoma, Recurrence, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡